Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM057732-003
Application #
3613259
Study Section
Project Start
1985-06-01
Project End
1990-04-30
Budget Start
1986-05-07
Budget End
1986-11-30
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Memorial Hospital for Cancer & Allied Di
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10021
Muindi, J F; Stevens, Y W; Warrell Jr, R P et al. (1993) In vitro differential metabolism of merbarone by xanthine oxidase and microsomal flavoenzymes. The role of reactive oxygen species. Drug Metab Dispos 21:410-4
Scher, H I; Jodrell, D I; Iversen, J M et al. (1992) Use of adaptive control with feedback to individualize suramin dosing. Cancer Res 52:64-70
Rigas, J R; Tong, W P; Kris, M G et al. (1992) Phase I clinical and pharmacological study of chloroquinoxaline sulfonamide. Cancer Res 52:6619-23
Berger, M Z; Kris, M G; Gralla, R J et al. (1991) Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer. Am J Clin Oncol 14:124-6
Muindi, J F; Lee, S J; Baltzer, L et al. (1991) Clinical pharmacology of deoxyspergualin in patients with advanced cancer. Cancer Res 51:3096-101
Casper, E S; Bajorin, D (1990) Phase II trial of carboplatin in patients with advanced melanoma. Invest New Drugs 8:187-90
Ginn, D; Kelsen, D; Eisenberger, M et al. (1990) Phase II trial of carboplatin and vinblastine in adenocarcinoma of the stomach. Invest New Drugs 8:321-4
Bajorin, D; Kelsen, D P (1990) A phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors. Cancer Invest 8:135-41
Kris, M G; D'Acquisto, R W; Gralla, R J et al. (1989) Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer. Am J Clin Oncol 12:24-6
Kemeny, N; Schneider, A; Martin, D S et al. (1989) Phase I trial of N-(phosphonacetyl)-L-aspartate, methotrexate, and 5-fluorouracil with leucovorin rescue in patients with advanced cancer. Cancer Res 49:4636-9

Showing the most recent 10 out of 18 publications